Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia

Citation
P. Brennan et al., Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia, BR J CANC, 82(7), 2000, pp. 1344-1347
Citations number
14
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
0007-0920 → ACNP
Volume
82
Issue
7
Year of publication
2000
Pages
1344 - 1347
Database
ISI
SICI code
0007-0920(200004)82:7<1344:SPNFNL>2.0.ZU;2-#
Abstract
The incidence of non-Hodgkin's lymphoma (NHL) has been increasing rapidly o ver the last three decades. The reasons for this trend are not known althou gh increasing exposure to sunlight has been postulated. We used data from t he New South Wales Central Cancer Registry to analyse second primary neopla sms following NHL diagnosed between 1972 and 1995, to identify possible com mon causal agents. A total of 12 452 patients contributed 54 308 person-yea rs of follow-up during which time there were 705 second primary neoplasms c ompared to 592.99 expected (standardized incidence ratio (SIR = 1.19, 95% c onfidence interval (CI) 1.10-1.28). There were excesses of melanomas of ski n (SIR = 2.38, 95% CI 1.92-2.91), lip cancer (SIR = 2.74, 95% CI 1.59-4.38) , tongue cancer (SIR = 2.53, 95% Cl 1.09-4.99) and bladder cancer (SIR = 1. 64, 95% CI 1.19-2.21). There was also over a threefold excess in soft tissu e sarcomas (SIR = 3.61, 95% CI 1.80-6.45) and in thyroid cancer (SIR = 3.42 , 95% CI 1.56-6.49). The SIR for myeloid leukaemia was 0.78 (95% CI 0.28-1. 69), The increases in melanoma of the skin and cancer of the lip and tongue among patients with NHL strongly suggest sunlight exposure as a shared cau sal agent. The increase in soft tissue sarcomas might be due to shared effe cts of exposure to chemicals such as phenoxy acid herbicides. The increases in bladder and thyroid cancers are likely to be explained by effects of tr eatment for NHL. We did not find a chemotherapy related increased risk of m yeloid leukaemia among NHL patients. (C) 2000 Cancer Research Campaign.